Blockade of the renin-angiotensin system with ACE inhibitors has already been shown to have analgesic effects in humans and in several models of neuropathic pain [5,40] induced by chronic constriction injury [6,8], insulin resistance [41], or streptozotocin-diabetes [9]. Here, ACE is linked to Insulin resistance.